FindTrial
Sign In

Development and application of AI-assisted electrocardiogram P-wave interpretation to predict recurrence after radiofrequency ablation of atrial fibrillation

Development and application of AI-assisted electrocardiogram P-wave interpretation to predict recurrence after radiofrequency ablation of atrial fibrillation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037473
Enrollment
Unknown
Registered
2020-08-28
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

Recurrence and non-recurrence of AF:Obtain the original ECG data and clinical desensitization information according to the regulations, no other intervention measures

Sponsors

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years; 2. Meet the diagnostic criteria for isolated and simple nonvalvular atrial fibrillation; 3. Receive radiofrequency ablation for atrial fibrillation for the first time; 4. Perfect transesophageal cardiac color ultrasound examination before surgery, and without left atrial thrombus.

Exclusion criteria

Exclusion criteria: 1. Valvular atrial fibrillation; 2. Recent myocardial infarction; 3. Severe chronic organic disease; 4. Have received cardiac surgery after radiofrequency ablation; 5. Implanted electronic devices or wires in the heart.

Design outcomes

Primary

MeasureTime frame
the recurrence of atrial fibrillation;—

Countries

China

Contacts

Public ContactYaosheng Wang

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

wangyaosheng@xinhuamed.com.cn+86 13651755978

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026